Skip to content
Holistic Vive

Holistic Vive

Health is the key to success and happiness

Primary Menu Holistic Vive

Holistic Vive

  • Blood Clotting Healthcare
  • Kidney Healthcare
  • Liver Healthcare
  • Liver Cancer Healthcare
  • Brain Healthcare and Neurology
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • rate

rate

VSee Health Secures 0K Enterprise Contract, Boosts Telehealth Success Rate by 88%
  • Kidney Healthcare

VSee Health Secures $200K Enterprise Contract, Boosts Telehealth Success Rate by 88%

admin February 15, 2025 0

VSee Health (NASDAQ: VSEE) has secured a $200K enterprise contract with a leading kidney care...

Read MoreRead more about VSee Health Secures $200K Enterprise Contract, Boosts Telehealth Success Rate by 88%
UK’s soaring liver cancer death rate blamed on alcohol and obesity | Cancer
  • Liver Cancer Healthcare

UK’s soaring liver cancer death rate blamed on alcohol and obesity | Cancer

admin January 4, 2024 0

One of the country’s leading health charities is calling for urgent action to reduce the “carcinogenic effects” of cheap alcohol...

Read MoreRead more about UK’s soaring liver cancer death rate blamed on alcohol and obesity | Cancer

Recent Posts

  • Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • AI in Liver Care Needs Vigilance and Tailoring to Population
  • Kidney Dialysis Equipment Market, In-Depth Analysis
  • KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Archives

Categories

  • Blood Clotting Healthcare
  • Brain Healthcare and Neurology
  • Kidney Healthcare
  • Liver Cancer Healthcare
  • Liver Healthcare

Visit Us

VISIT BRAZIL

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • Liver Cancer Healthcare

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0
AI in Liver Care Needs Vigilance and Tailoring to Population
  • Liver Healthcare

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0
Kidney Dialysis Equipment Market, In-Depth Analysis
  • Kidney Healthcare

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0
KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • Liver Cancer Healthcare

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
  • Liver Healthcare

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0
Copyright © All rights reserved. | CoverNews by AF themes.